Key result
Lower bi-atrial reservoir strain is linked to ~9% higher mortality per unit drop in ATTR-CM.
Why the study?
Do left and right atrial reservoir strain predict all-cause mortality and heart failure hospitalizations in patients with ATTR-CM?
Cohort (n=89)
Blinded investigators
No
Do left and right atrial reservoir strain predict all-cause mortality and heart failure hospitalizations in patients with ATTR-CM?
Answers are grounded in this paper and cite their sources.
Left and right atrial reservoir strain independently predict mortality, and right atrial strain predicts heart failure hospitalizations in patients with ATTR-CM.
Aim This study aimed to evaluate the prognostic value of left and right atrial reservoir strain (LASr, RASr) regarding all-cause mortality and hospitalization due to worsening heart failure (WHF) in patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM). Methods In this analysis of the prospective Graz hypertrophic cardiomyopathy registry, 89 patients were enrolled for post-processing analyses of echocardiographic studies, performed by blinded investigators. All patients included between February 2019 and October 2023 with a confirmed diagnosis of ATTR-CM according to current guidelines and adequate echocardiographic image quality were enrolled. Patients’ outcomes were retrieved from local medical and health insurance records. Results Median age was 79 (76-82) years, including 10 (11%) women. During a median (interquartile range) follow up of 3 (2-4) years, 29 (33%) patients died, and 27 (30%) patients were hospitalized due to WHF (as seen in the table below). In univariable Cox-regression analysis, LASr and RASr were significantly associated with mortality (LASr HR = 0.898 [95% CI 0.828-0.974], p = 0.009; RASr HR = 0.911 [95% CI 0.859-0.966], p = 0.002) and RASr was significantly associated with WHF hospitalizations (HR = 0.931 [95% CI 0.882-0.983], p = 0.010). According to the ROC analysis, optimal cut-off values for risk-prediction of mortality were 11% for LASr (52% sensitivity, 81% specificity) and 13% for RASr (57% sensitivity, 83% specificity). In a multivariable Cox-regression model adjusted for age, sex, atrial fibrillation, and treatment with tafamidis, LASr and RASr were independent predictors for mortality (LASr HR = 0.912 [95% CI 0.833-0.997], p = 0.043; RASr HR = 0.875 [95% CI 0.804-0.951], p = 0.002). Cumulative survival is visualized in the figure below. In the adjusted model, RASr further remained an independent predictor of WHF hospitalizations (HR = 0.891 [95% CI 0.823–0.965], p = 0.004). Conclusion LASr and RASr are independent predictors for mortality in patients with ATTR-CM, and RASr independently predicts WHF hospitalizations. Further studies are warranted to elucidate on the value of LASr and RASr in prognostic assessments for these patients in clinical practice.
No takes yet. Share an insight, caveat, or question.
Winkelbauer et al. (2025) conducted a cohort in Transthyretin Amyloid Cardiomyopathy (ATTR-CM) (n=89). Left and right atrial reservoir strain (LASr, RASr) was evaluated on All-cause mortality (HR 0.912, 95% CI 0.833-0.997, p=0.043). Left and right atrial reservoir strain independently predicted all-cause mortality in ATTR-CM patients.
Synapse has enriched 10 related papers. Consider them for comparative context: